bf/NYSE:TEVA_icon.png

COM:TEVAPHARM

Teva Pharmaceutical Industries Ltd.

  • Stock

USD

Last Close

17.08

22/11 21:00

Market Cap

19.23B

Beta: -

Volume Today

6.01M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
1.25B
-
3.04B
142.78%
1.60B
47.50%
311M
80.53%
-16.45B
5,389.07%
-2.47B
84.97%
76M
103.07%
-4.10B
5,493.42%
456M
111.12%
-2.41B
627.63%
-615M
74.44%
depreciation and amortization
1.64B
-
1.51B
8.16%
1.31B
13.26%
1.52B
16.51%
2.11B
38.58%
1.84B
12.78%
416M
77.42%
1.56B
274.28%
1.33B
14.58%
1.31B
1.65%
1.15B
11.85%
deferred income tax
-1.38B
-
-226M
83.62%
237M
204.87%
15M
93.67%
-2.33B
15,640%
-837M
64.09%
-333M
60.22%
-696M
109.01%
-120M
82.76%
-1.06B
782.50%
-317M
70.07%
stock based compensation
64M
-
95M
48.44%
117M
23.16%
124M
5.98%
133M
7.26%
155M
16.54%
20M
87.10%
129M
545%
119M
7.75%
124M
4.20%
121M
2.42%
change in working capital
968M
-
290M
70.04%
967M
233.45%
1.22B
26.06%
-363M
129.78%
-1.82B
402.20%
-112M
93.86%
-2.19B
1,853.57%
-1.70B
22.26%
1.26B
173.90%
-72M
105.73%
accounts receivables
85M
-
710M
735.29%
763M
7.46%
343M
55.05%
514M
49.85%
88M
82.88%
-394M
547.73%
-293M
25.63%
-574M
95.90%
334M
158.19%
12M
96.41%
inventory
399M
-
230M
42.36%
129M
43.91%
753M
483.72%
266M
64.67%
26M
90.23%
271M
942.31%
41M
84.87%
380M
826.83%
-163M
142.89%
-147M
9.82%
accounts payables
378M
-
-614M
262.43%
-12M
98.05%
640M
5,433.33%
-1.80B
381.41%
-500M
72.24%
643M
228.60%
-463M
172.01%
764M
265.01%
1.91B
150.52%
1.59B
17.03%
other working capital
212M
-
-72M
133.96%
174M
341.67%
-1.03B
694.25%
1.32B
227.27%
-1.44B
209.19%
-632M
56.02%
-1.47B
133.07%
-2.27B
54.18%
-828M
63.54%
-1.52B
84.18%
other non cash items
690M
-
418M
39.42%
1.32B
214.83%
2.03B
54.41%
20.41B
904.18%
5.58B
72.65%
471M
91.56%
6.51B
1,282.80%
714M
89.04%
2.37B
231.37%
1.10B
53.59%
net cash provided by operating activities
3.24B
-
5.13B
58.39%
5.54B
8.09%
5.22B
5.72%
3.51B
32.88%
2.45B
30.25%
538M
78.00%
1.22B
126.02%
798M
34.38%
1.59B
99.25%
1.37B
13.96%
investments in property plant and equipment
-1.03B
-
-929M
9.89%
-772M
16.90%
-901M
16.71%
-874M
3.00%
-651M
25.51%
-119M
81.72%
-578M
385.71%
-562M
2.77%
-548M
2.49%
-526M
4.01%
acquisitions net
-39M
-
-363M
830.77%
-3.31B
811.57%
-36.15B
992.41%
43M
100.12%
1.74B
3,934.88%
-343M
119.77%
67M
119.53%
1.96B
2,823.88%
61M
96.89%
68M
11.48%
purchases of investments
-160M
-
-324M
102.50%
-2.00B
518.21%
-481M
75.99%
-200M
58.42%
-119M
40.50%
-3M
97.48%
-55M
1,733.33%
-47M
14.55%
-1M
97.87%
-46M
4,500%
sales maturities of investments
187M
-
196M
4.81%
524M
167.35%
2.00B
282.06%
3.48B
73.68%
890M
74.40%
343M
61.46%
12M
96.50%
172M
1,333.33%
4M
97.67%
1.48B
36,825%
other investing activites
83M
-
166M
100%
519M
212.65%
1.79B
244.89%
3.19B
78.49%
11M
99.66%
552M
4,918.18%
1.42B
156.70%
1M
99.93%
1.14B
113,900%
-5M
100.44%
net cash used for investing activites
-1.15B
-
-1.45B
26.42%
-5.57B
283.79%
-35.74B
542.23%
2.16B
106.05%
1.87B
13.77%
430M
76.96%
863M
100.70%
1.52B
76.48%
656M
56.93%
968M
47.56%
debt repayment
-3.13B
-
-839M
73.22%
-2.52B
200.48%
-999M
60.37%
-3.30B
230.33%
-7.45B
125.64%
-2.23B
70.06%
-2.43B
9.02%
-7.84B
222.63%
-1.37B
82.54%
-4.85B
254.42%
common stock issued
813M
-
129M
84.13%
3.29B
2,451.16%
329M
90.00%
common stock repurchased
-497M
-
-500M
0.60%
-439M
12.20%
27.61B
6,390.21%
dividends paid
-1.09B
-
-1.16B
6.15%
-1.16B
0.09%
-1.56B
34.89%
-1.16B
25.48%
-22M
98.11%
-52M
136.36%
other financing activites
836M
-
120M
85.65%
5.63B
4,590.83%
27.45B
387.56%
-1.29B
104.70%
4.12B
419.39%
2.04B
50.45%
545M
73.28%
5.67B
940%
-118M
102.08%
2.94B
2,590.68%
net cash used provided by financing activities
-3.88B
-
-2.38B
38.84%
4.80B
302.32%
25.22B
424.81%
-5.75B
122.80%
-3.35B
41.72%
-241M
92.81%
-1.89B
682.16%
-2.17B
15.23%
-1.49B
31.54%
-1.91B
28.65%
effect of forex changes on cash
-48M
-
-114M
137.50%
-62M
45.61%
-660M
964.52%
54M
108.18%
-142M
362.96%
7M
104.93%
8M
14.29%
-128M
1,700%
-123M
3.91%
-30M
75.61%
net change in cash
-1.84B
-
1.19B
164.53%
4.72B
297.31%
-5.96B
226.23%
-25M
99.58%
819M
3,376%
734M
10.38%
202M
72.48%
21M
89.60%
636M
2,928.57%
393M
38.21%
cash at beginning of period
2.88B
-
1.04B
63.95%
2.23B
114.45%
6.95B
212.04%
988M
85.78%
963M
2.53%
1.24B
28.87%
1.98B
59.15%
2.18B
10.23%
2.20B
0.96%
2.83B
28.94%
cash at end of period
1.04B
-
2.23B
114.45%
6.95B
212.04%
988M
85.78%
963M
2.53%
1.78B
85.05%
1.98B
10.83%
2.18B
10.23%
2.20B
0.96%
2.83B
28.94%
3.23B
13.87%
operating cash flow
3.24B
-
5.13B
58.39%
5.54B
8.09%
5.22B
5.72%
3.51B
32.88%
2.45B
30.25%
538M
78.00%
1.22B
126.02%
798M
34.38%
1.59B
99.25%
1.37B
13.96%
capital expenditure
-1.03B
-
-929M
9.89%
-772M
16.90%
-901M
16.71%
-874M
3.00%
-651M
25.51%
-119M
81.72%
-578M
385.71%
-562M
2.77%
-548M
2.49%
-526M
4.01%
free cash flow
2.21B
-
4.20B
90.30%
4.77B
13.63%
4.32B
9.35%
2.63B
39.11%
1.79B
31.83%
419M
76.66%
638M
52.27%
236M
63.01%
1.04B
341.53%
842M
19.19%

All numbers in USD (except ratios and percentages)